Biological Context of MPK10
MPK10 is a member of the MAP kinase family involved in:
-
Plant development: Regulation of endosperm growth via cross-inhibition with transcription factor WRKY10 in Arabidopsis
-
Parasite differentiation: Stage-specific activation during Leishmania amastigote development, critical for host adaptation
Key Applications of MPK10 Antibody
| Application | Experimental Context | Key Findings |
|---|
| Co-immunoprecipitation (Co-IP) | Arabidopsis endosperm studies | Confirmed physical interaction between MPK10 and WRKY10 using GFP-tagged constructs |
| Kinase Activity Assays | Leishmania axenic amastigotes | Quantified stage-specific MPK10 activation via radioactive MBP phosphorylation assays |
| Subcellular Localization | Dual-luciferase assays in N. benthamiana | Identified MPK10-mediated suppression of WRKY10 transcriptional activity |
Regulatory Mechanisms
-
Auto-inhibition: In Leishmania, MPK10’s C-terminal domain (aa 368–485) suppresses kinase activity until environmental triggers (e.g., pH/temperature shifts) relieve this inhibition .
-
Cross-species conservation: Despite 90%+ sequence identity in Leishmania species, functional divergence exists in plant vs. parasite systems .
Functional Insights
-
Plant studies:
-
mpk10 mutants showed 2.5-fold increased WRKY10 expression (2DAP seeds, P < 0.01) .
-
MPK10 knockdown led to 18% larger seeds due to deregulated endosperm expansion .
-
Parasite studies:
Technical Considerations for MPK10 Antibodies
| Parameter | Requirement |
|---|
| Specificity | Must distinguish phosphorylated (TxY motif) vs. inactive forms |
| Species Reactivity | Separate antibodies needed for plant (Arabidopsis) vs. protozoan (Leishmania) targets |
| Validation | Requires knockout controls (e.g., mpk10 mutants) to confirm signal absence |
Challenges and Future Directions